Cur Med Res Opinion 2007;23(7):1509-15
Economic impact of gefitinib for refractory non-small-cell lung cancer: a Markov model-based analysis
[pdf]Cur Med Res Opinion 2007_23_7_1509-15[/pdf]
Economic impact of gefitinib for refractory non-small-cell lung cancer: a Markov model-based analysis
[pdf]Cur Med Res Opinion 2007_23_7_1509-15[/pdf]